Introduction to Materials of Construction & Corrosion
Selecting the right material for pharmaceutical equipment is critical for product safety, regulatory compliance, and equipment longevity. The wrong material can contaminate drugs, corrode in aggressive cleaning agents (CIP/SIP cycles), and cause regulatory failures. This unit covers the science of material selection and corrosion prevention.
Syllabus & Topics
- 1Materials of Pharmaceutical Plant Construction – Overview: Selection must consider: chemical compatibility with drug/solvent, corrosion resistance, mechanical strength, ease of cleaning and sterilization (CIP/SIP), surface finish (Ra roughness), regulatory acceptance (ASME BPE, FDA).
- 2Factors Affecting Material Selection for Pharmaceutical Plants:
- 3(1) Chemical resistance: Must be inert to drugs, solvents, cleaning agents (NaOH, HCl, H2O2), sanitizing agents.
- 4(2) Thermal stability: Must withstand SIP temperatures (121-134°C steam).
- 5(3) Surface finish: Smooth (Ra ≤ 0.8 µm) to prevent microbial adhesion and facilitate cleaning.
- 6(4) Mechanical strength: Must withstand process pressures, stresses.
- 7(5) Compliance: Must meet USP Class VI plastic testing, ASME-BPE, EC 1935/2004.
- 8(6) Cost consideration.
- 9Theories of Corrosion:
- 10Chemical (Direct) Corrosion Theory: Metal reacts directly with corrosive substance (e.g., Fe + H2SO4 → FeSO4 + H2).
- 11Electrochemical Corrosion Theory: Most important. Requires: two electrodes (anode + cathode), electrolyte solution, metallic path. Anode: oxidation (metal → metal ions + electrons). Cathode: reduction (H2O/O2 reduced). Cell potential drives corrosion.
- 12Types of Corrosion:
- 13(1) Uniform (General) Corrosion: Even attack over entire surface; predictable rate; monitored by corrosion coupons.
- 14(2) Galvanic Corrosion: When two dissimilar metals (different EMF) in contact in electrolyte; less noble metal (anode) corrodes faster. Prevention: use same metal or insulating gaskets.
- 15(3) Pitting Corrosion: Localized attack forming deep pits; dangerous; hard to detect; common in stainless steel when passive film breaks (chloride). Prevention: use Mo-containing SS (316L).
- 16(4) Crevice Corrosion: In narrow gaps (crevices) where electrolyte is stagnant; O2 depletion → anode. Prevent by eliminating crevices (welded joints, gasket design).
- 17(5) Stress Corrosion Cracking (SCC): Combined effect of tensile stress + corrosive environment; catastrophic failure; stainless steel vulnerable to chloride SCC.
- 18(6) Intergranular Corrosion: Sensitization of SS when heated 450-850°C; Cr23C6 precipitates at grain boundaries, depleting Cr; use Low Carbon SS (316L) or stabilized grades (321, 347) to prevent.
- 19(7) Erosion Corrosion: Combined mechanical erosion + corrosion; in pump impellers, pipe bends.
- 20Prevention of Corrosion: Material selection (316L SS), Cathodic protection, Protective coatings (electroplating, passivation), Design (eliminate crevices), Corrosion inhibitors.
- 21Ferrous Metals:
- 22Carbon Steel: Strong, cheap but corrodes; used only for non-product-contact parts (structural).
Learning Objectives
Frequently Asked Questions (FAQs)
Q1. Why is SS 316L (Not SS 304 or 316) Used for Pharmaceutical Equipment?
SS 316L contains low carbon (0.03% vs 0.08% in 316), which prevents sensitization and intergranular corrosion during welding. It also contains 2–3% molybdenum, providing superior resistance to pitting and crevice corrosion, especially against chlorides present in CIP solutions such as hydrochloric acid. It allows excellent surface finish (Ra ≤ 0.8 µm) and is recognized by regulatory standards for GMP pharmaceutical use, making it the gold standard material for pharma equipment.
Q2. What is Pitting Corrosion and How is it Prevented?
Pitting corrosion is a localized and highly destructive form of corrosion that forms small pits or craters on a metal surface while the surrounding area appears intact. It occurs due to breakdown of the protective chromium oxide (Cr₂O₃) passive layer by chloride ions (Cl⁻). It is particularly dangerous because it is difficult to detect early and can perforate thin-walled equipment. Prevention methods include using molybdenum-containing SS 316L, avoiding chloride-containing cleaning agents, applying electropolished finishes, and performing passivation (e.g., citric acid treatment).
Q3. What is the Difference Between Type I and Type III Glass?
Type I (borosilicate glass) has high chemical resistance, low thermal expansion, and strong hydrolytic resistance, and is used for ampoules, vials, and parenteral containers such as IV, ophthalmic, and biological products. Type II (treated soda lime glass) has moderate resistance and is used for aqueous parenterals (non-biological). Type III (untreated soda lime glass) has lower chemical resistance and is used for oral solid and liquid containers. Type NP (non-parenteral) glass has the least resistance and is used for non-parenteral products.
Q4. What is Electrochemical Corrosion?
Electrochemical corrosion is the most common corrosion mechanism and requires four components: (1) Anode, where oxidation occurs (M → Mⁿ⁺ + ne⁻); (2) Cathode, where reduction occurs (O₂ + H₂O + e⁻ → OH⁻ or H⁺ + e⁻ → H₂); (3) Electrolyte, which conducts ions; and (4) Metallic path for electron flow. Examples include rusting of iron and pitting of stainless steel. Corrosion can be prevented by eliminating any one of these four components.
Q5. What are the Advantages of PTFE (Teflon) as a Pharmaceutical Material?
Polytetrafluoroethylene (PTFE, commonly known as Teflon) is virtually chemically inert and resistant to acids, bases, solvents, and oxidizing agents. It has a non-stick surface that prevents protein or product adhesion, a wide operating temperature range (–200°C to +260°C), is FDA-compliant for food and drug contact, and is non-toxic and non-reactive. It is used in gaskets and seals for sterile filling equipment, tubing for aggressive chemicals, PTFE-lined reactors, valve seats, and laboratory containers.